General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist
- 6 March 1995
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 34 (3) , 276-288
- https://doi.org/10.1002/ddr.430340305
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functionsTrends in Pharmacological Sciences, 1994
- Suppression of non-esterified fatty acids to treat type A insulin resistance syndromeThe Lancet, 1994
- Adenosine receptor subtypesTrends in Pharmacological Sciences, 1993
- SDZ 216–525, a selective and potent 5-HT1A receptor antagonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Adenosine and cardiac arrhythmias.BMJ, 1992
- Adenosine receptors and cardiovascular functionTrends in Cardiovascular Medicine, 1992
- Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes MellitusDiabetes Care, 1992
- Adenosine and Supraventricular TachycardiaNew England Journal of Medicine, 1991
- A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetryClinical and Experimental Hypertension. Part A: Theory and Practice, 1991
- Adenosine receptors mediating cardiac depressionLife Sciences, 1982